Hans Olof Glise
Chairman at Ith Immune Therapy Holdings AB
Profile
Hans Olof Glise is the founder of ITH Europe AS.
He is currently the Chairman at Ith Immune Therapy Holdings AB and TLA Targeted Immunotherapies AB.
He previously served as Chairman at Nanofactory Instruments AB, Director at ISR Immune System Regulation Holding AB, Vice President at Astra Zeneca Holding France SAS, and Senior Vice President at Novo Nordisk Scandinavia AB.
Hans Olof Glise active positions
| Companies | Position | Start |
|---|---|---|
| Ith Immune Therapy Holdings AB | Chairman | - |
TLA Targeted Immunotherapies AB
 TLA Targeted Immunotherapies AB Electronic Equipment/InstrumentsElectronic Technology TLA Targeted Immunotherapies AB manufactures medical devices. The private company is based in Stockholm, Sweden. | Chairman | - |
Former positions of Hans Olof Glise
| Companies | Position | End |
|---|---|---|
Nanofactory Instruments AB
 Nanofactory Instruments AB Medical SpecialtiesHealth Technology Nanofactory Instruments AB develops and manufactures nanotechnology tools for manipulation, measurement and imaging on the atomic scale. It offers services in the fields of materials science, information technology and biotechnology. The company operates in North America, Latin America, Europe, India, Israel, Africa and the Middle East. Nanofactory Instruments was founded in 1999 and is headquartered in Gothenburg, Sweden. | Chairman | 2014-02-10 |
Novo Nordisk Scandinavia AB
 Novo Nordisk Scandinavia AB Pharmaceuticals: MajorHealth Technology Novo Nordisk Scandinavia AB develops, manufactures and markets pharmaceutical products and services. Its products include medicine for diabetes, hemophilia, growth disorders, and hormone therapy. The company is headquartered in Malmö, Sweden. | Corporate Officer/Principal | - |
| ITH Europe AS | Founder | - |
Astra Zeneca Holding France SAS
 Astra Zeneca Holding France SAS Pharmaceuticals: MajorHealth Technology Astra Zeneca Holding France SAS operates as a holding firm with interest in pharmaceuticals. The company was founded in 1994 and is headquartered in Rueil-Malmaison, France. | Corporate Officer/Principal | - |
| ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL) | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Nanofactory Instruments AB
Nanofactory Instruments AB Medical SpecialtiesHealth Technology Nanofactory Instruments AB develops and manufactures nanotechnology tools for manipulation, measurement and imaging on the atomic scale. It offers services in the fields of materials science, information technology and biotechnology. The company operates in North America, Latin America, Europe, India, Israel, Africa and the Middle East. Nanofactory Instruments was founded in 1999 and is headquartered in Gothenburg, Sweden. | Health Technology |
Astra Zeneca Holding France SAS
Astra Zeneca Holding France SAS Pharmaceuticals: MajorHealth Technology Astra Zeneca Holding France SAS operates as a holding firm with interest in pharmaceuticals. The company was founded in 1994 and is headquartered in Rueil-Malmaison, France. | Health Technology |
Novo Nordisk Scandinavia AB
Novo Nordisk Scandinavia AB Pharmaceuticals: MajorHealth Technology Novo Nordisk Scandinavia AB develops, manufactures and markets pharmaceutical products and services. Its products include medicine for diabetes, hemophilia, growth disorders, and hormone therapy. The company is headquartered in Malmö, Sweden. | Health Technology |
| Ith Immune Therapy Holdings AB | |
TLA Targeted Immunotherapies AB
TLA Targeted Immunotherapies AB Electronic Equipment/InstrumentsElectronic Technology TLA Targeted Immunotherapies AB manufactures medical devices. The private company is based in Stockholm, Sweden. | Electronic Technology |
| ITH Europe AS | |
ISR Immune System Regulation Holding AB
 ISR Immune System Regulation Holding AB Pharmaceuticals: MajorHealth Technology ISR Immune System Regulation Holding AB engages in pharmaceutical research for the treatment of viral diseases focusing on Human Immunodeficiency Virus (HIV). It is developing ISR048 for the novel treatment of HIV. The company was founded by Yen Lundgren and Ulf Ljungblad in September 17, 2015 and is headquartered in Solna, Sweden. | Health Technology |
- Stock Market
- Insiders
- Hans Olof Glise
